Fact CheckerSign in

NCT06550310Recruiting

Nutrition and Clinical Outcomes in IBD

Nutrition and Body Composition and Association With Clinical Outcomes in Inflammatory Bowel Disease

Source: ClinicalTrials.gov · Last updated 19 Feb 2026

Brief summary (registry, in English)

The goal of this observational study is to demonstrate that nutritional status and body composition have an impact on clinical outcomes in inflammatory bowel disease (IBD). The main objectives are: 1. To compare the detection rates of undernutrition between a range of nutritional screening tools, physiological measures and assessment tools amongst patients with different IBD phenotypes 2. To correlate nutritional status, nutritional biomarkers and body composition with clinical outcomes in patients with IBD treated with advanced medical therapy or surgery 3. To determine a potential relationship between radiological muscle mass measurements and clinical outcomes in patients with IBD treated with advanced medical therapy or surgery Participants will undergo an assessment at pre-treatment baseline and then again at their scheduled follow-up. This is a non-interventional study and participants will not be required to have any invasive tests or hospital visits beyond that of standard clinical care.

Status (registry)
Recruiting
Study type
Observational
Enrollment
300 (estimated)
First submitted
31 Jul 2024
Start date
24 Oct 2024
Primary completion date
May 2028
Lead sponsor
Barts & The London NHS Trust
NCT number
NCT06550310

What you commit to

  • Study type: Observational
  • Planned participants: 300
  • From 24 Oct 2024 to the primary completion date, May 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with a cardiac pacemaker or internal defibrillator
  • Patients with active cancer and other disorders associated with severe cachexia

Age

  • Patients below the age of 16

Other

  • Patients who cannot provide informed consent

Who the study is looking for

  • Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis or IBD-U) starting a new advanced medical therapy
  • Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis or IBD-U) undergoing an IBD-related surgery
  • Age \>16
  • Patients able and willing to provide written informed consent

Age in the registry: 16 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Barts Health NHS Trust
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.